InvestorsHub Logo
Followers 0
Posts 127
Boards Moderated 0
Alias Born 08/06/2016

Re: None

Thursday, 10/25/2018 11:27:38 AM

Thursday, October 25, 2018 11:27:38 AM

Post# of 38634
Big push above $1 will happen anytime now to keep stock on Nasdaq likely on imminent clinical results and NDA resubmission . Its definitely a great buy here to make quick money in the coming weeks and months before FDA decision .GLTA


Bioanalytical samples and statistical analysis for such studies are pending. An update on the results will be provided once the analysis is complete.

The FDA granted our request for an extension to February 28, 2019 to resubmit our NDA for Oxycodone ER under section 505(b)(2) of the U.S. Federal Food, Drug and Cosmetic Act. However, we plan to resubmit the application later this year.